Departments of Diagnostic and Interventional Imaging, University of Texas Health Science Center at Houston (UTHealth Houston), Houston, Texas.
Departments of Neurology, University of Texas Health Science Center at Houston (UTHealth Houston), Houston, Texas.
Brain Behav. 2023 Jul;13(7):e3042. doi: 10.1002/brb3.3042. Epub 2023 May 22.
The discovery of glymphatic function in the human brain has generated interest in waste clearance mechanisms in neurological disorders such as multiple sclerosis (MS). However, noninvasive in vivo functional assessment is currently lacking. This work studies the feasibility of a novel intravenous dynamic contrast MRI method to assess the dural lymphatics, a purported pathway contributing to glymphatic clearance.
This prospective study included 20 patients with MS (17 women; age = 46.4 [27, 65] years; disease duration = 13.6 [2.1, 38.0] years, expanded disability status score (EDSS) = 2.0 [0, 6.5]). Patients were scanned on a 3.0T MRI system using intravenous contrast-enhanced fluid-attenuated inversion recovery MRI. Signal in the dural lymphatic vessel along the superior sagittal sinus was measured to calculate peak enhancement, time to maximum enhancement, wash-in and washout slopes, and the area under the time-intensity curve (AUC). Correlation analysis was performed to examine the relationship between the lymphatic dynamic parameters and the demographic and clinical characteristics, including the lesion load and the brain parenchymal fraction (BPF).
Contrast enhancement was detected in the dural lymphatics in most patients 2-3 min after contrast administration. BPF had a significant correlation with AUC (p < .03), peak enhancement (p < .01), and wash-in slope (p = .01). Lymphatic dynamic parameters did not correlate with age, BMI, disease duration, EDSS, or lesion load. Moderate trends were observed for correlation between patient age and AUC (p = .062), BMI and peak enhancement (p = .059), and BMI and AUC (p = .093).
Intravenous dynamic contrast MRI of the dural lymphatics is feasible and may be useful in characterizing its hydrodynamics in neurological diseases.
人类大脑中发现的糖质运输功能引起了人们对多发性硬化症(MS)等神经疾病中废物清除机制的兴趣。然而,目前缺乏非侵入性的体内功能评估。本研究旨在探讨一种新的静脉内动态对比 MRI 方法评估硬脑膜淋巴管(被认为是参与糖质运输清除的途径)的可行性。
本前瞻性研究纳入了 20 例 MS 患者(17 名女性;年龄=46.4[27,65]岁;病程=13.6[2.1,38.0]年,扩展残疾状况评分(EDSS)=2.0[0,6.5])。患者在 3.0T MRI 系统上进行静脉内对比增强液体衰减反转恢复 MRI 扫描。测量沿上矢状窦的硬脑膜淋巴管中的信号,以计算峰值增强、达到最大增强的时间、洗入和洗出斜率以及时间-强度曲线下面积(AUC)。进行相关分析以检查淋巴管动力学参数与人口统计学和临床特征(包括病变负荷和脑实质分数(BPF))之间的关系。
大多数患者在对比剂给药后 2-3 分钟检测到硬脑膜淋巴管的对比增强。BPF 与 AUC(p<.03)、峰值增强(p<.01)和洗入斜率(p=.01)显著相关。淋巴管动力学参数与年龄、BMI、病程、EDSS 或病变负荷无关。年龄与 AUC(p=.062)、BMI 与峰值增强(p=.059)以及 BMI 与 AUC(p=.093)之间存在中等相关性的趋势。
硬脑膜淋巴管的静脉内动态对比 MRI 是可行的,可能有助于描述神经疾病中其流体动力学特性。